Morgan Stanley raises Paychex price target to $109

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Morgan Stanley analyst James Faucette maintained an Equal-Weight rating on Paychex and increased the price target to $109 from $107, signaling a modestly improved valuation outlook.

powered bylight_fuzz_icon
44375436

*this image is generated using AI for illustrative purposes only.

Morgan Stanley analyst James Faucette has maintained an Equal-Weight rating on Paychex while raising the price target to $109 from $107. The revised target suggests a modest adjustment in the firm's valuation outlook for the payroll services company.

Rating and Price Target Details

The research note from Morgan Stanley confirms the retention of the Equal-Weight status for Paychex shares. The primary change in the report is the upward revision of the price objective.

Metric Value
Rating Equal-Weight
Previous Price Target $107
New Price Target $109

The decision to raise the price target indicates a slight shift in expectations, though the Equal-Weight rating implies that the stock is expected to perform largely in line with the broader market or sector averages.

What factors might drive further upward revisions to Paychex's price target in the future?

How could changes in employment trends impact Paychex's performance relative to market expectations?

What competitive pressures could challenge Paychex's ability to maintain its Equal-Weight rating?

like16
dislike

UBS maintains Neutral on Paychex, lowers target to $98

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

UBS analyst Kevin Mcveigh maintains a Neutral rating on Paychex (NASDAQ: PAYX) while lowering the price target to $98 from the previous $100.

powered bylight_fuzz_icon
43948628

*this image is generated using AI for illustrative purposes only.

UBS analyst Kevin Mcveigh maintains Paychex (NASDAQ: PAYX) with a Neutral rating and lowers the price target to $98 from $100. The adjustment reflects a revised valuation outlook for the stock listed on NASDAQ.

Rating and Target Details

The research note updates the investment stance on Paychex without altering the Neutral recommendation. The price target reduction indicates a shift in the firm's expectations for the stock's performance.

Metric Value
Rating Neutral
Previous Price Target $100
New Price Target $98

What factors contributed to the revised valuation outlook for Paychex?

How might this price target adjustment influence investor sentiment toward Paychex?

What are the potential risks or opportunities for Paychex in the current market environment?

like15
dislike

More News on Paychex Inc